Quantrx Biomedical Corporation (QTXB) Return on Investment ROI from the third quarter of 2022 to third quarter of 2021 and for the year 2022, average high and low, overall ranking from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Quantrx Biomedical Corporation  (QTXB)


Quantrx Biomedical's ROI from its third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Quantrx Biomedical's ROI in the third quarter of 2022?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Quantrx Biomedical Corporation's return on investment (ROI) in its third quarter of 2022

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 0 -3 -3 0 -2
Return On Investment (TTM) 21.28 % - - 14.84 % -
QTXB's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 0 0 0 0 0

QTXB Company Profile >> Back to QTXB Roi Comparisons >> See Annual QTXB Return On Investment



Return On Investment QTXB's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Quantrx Biomedical's III. Quarter Investments $ 0 Millions QTXB's Balance sheet
Quantrx Biomedical's III. Quarter Income $ 0 Millions Quarterly QTXB's Income Statement
QTXB's Income by Division See QTXB's Income by Division


QTXB Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Investments in Millions -2 -2 -2 -2 -1
Y / Y Investment Growth - - - - -
Net Income in Millions 0 0 -1 -1 1
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - - - -


Annual Roi Comment
Despite deterioration in net income, company improved ROI to in the fiscal year 2021, company improved ROI to 1 % compare to previous year.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
QTXB's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for QTXB's Competitors
Subscribers only: Roi for Quantrx Biomedical's Suppliers
Subscribers only: Return On Investment for QTXB's Customers

Other Ratios
QTXB's Roa QTXB's Inventory Turnover Ratio QTXB's Growth Rates QTXB's Dividend Statistics
QTXB's Profitability Ratios QTXB's Asset Turnover Ratio QTXB's Dividend Growth
QTXB's Roe QTXB's Valuation Ratios QTXB's Financial Strength Ratios QTXB's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2022, within Healthcare Sector ROI
Glucotrack Inc   54.64 %
Vir Biotechnology Inc   53.95 %
Dynavax Technologies Corporation  52.91 %
Oncotelic Therapeutics Inc   48.74 %
Journey Medical Corp  45.06 %
Biofrontera Inc   44.78 %
Idexx Laboratories Inc  41.99 %
REST EZ Inc.  41.68 %
Iteos Therapeutics Inc   40.85 %
Prophase Labs Inc   39.24 %
Mettler toledo International Inc   38.09 %
Orgenesis Inc   37.05 %
Vicarious Surgical Inc  36.26 %
Harmony Biosciences Holdings inc   35.33 %
Nrc Health  33.19 %
Exelixis Inc   32.97 %
Avid Bioservices Inc   32.85 %
Embecta Corp   31.85 %
Cartesian Therapeutics Inc   31.06 %
Innoviva Inc   29.72 %
Catalyst Pharmaceuticals Inc   27.65 %
Corcept Therapeutics Inc  27.25 %
Medpace Holdings Inc   27.00 %
Ir med Inc   26.71 %
Vertex Pharmaceuticals Inc  25.93 %
Aptevo Therapeutics Inc   25.88 %
Dariohealth Corp   25.43 %
Semler Scientific inc   25.41 %
Shockwave Medical Inc   25.37 %
Gyre Therapeutics Inc   24.33 %

Date modified: 2026-09-08T15:10:47+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.